Mallinckrodt® Institute

Mallinckrodt has had a long-standing commitment to supporting global excellence in clinical education and training related to autologous immunotherapy delivered through extracorporeal photopheresis (ECP). The Therakos® Institute extends our current education and advocacy efforts by offering state-of-the-art teaching tools and approaches, including new operator training modules; engaging leading thought leaders and practice innovators; supporting Centers of Excellence for treatment of  cutaneous T-cell lymphoma (CTCL), graft versus host disease (GHVD), and solid organ transplant (SOT) rejection; and recognising important research achievements in the field.

Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company.


© 2018 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at Damastown, Mulhuddart, Dublin 15, Ireland.